GlassScriptPhysician profile
Kim M Ham
NPI 1417377540
$6,706.60
in general payments reported to CMS, 2019-2025
37 companies · $1,388 in 2025
The $1,388 reported for 2025 was more than what 89% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,444 · 2022: $1,148 · 2023: $1,228 · 2024: $1,499 · 2025: $1,388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,114.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $921.48 | 2021-2022 | |
| Pfizer INC. | $673.27 | 2021-2025 | |
| Abbvie INC. | $557.79 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $544.31 | 2021-2024 | Austedo Xr, Austedo |
| Otsuka America Pharmaceutical, INC. | $465.82 | 2023-2025 | Rexulti, Nuedexta |
| Ucb, INC. | $423.78 | 2023-2025 | Nayzilam, Briviact |
| Lundbeck LLC | $393.19 | 2023-2025 | Rexulti, Vyepti |
| Eisai INC. | $347.41 | 2024-2025 | |
| Lilly USA, LLC | $273.47 | 2023-2025 | Kisunla, Amyvid |
| Neurocrine Biosciences, INC. | $212.85 | 2022-2025 | Ingrezza, Ongentys |
| Biohaven Pharmaceuticals, INC. | $204.33 | 2021 | |
| Abbott Laboratories | $177.42 | 2023 | Infinity, Amplatzer Talisman |
| Amgen INC. | $158.04 | 2021-2022 | |
| Biogen, INC. | $150.64 | 2021-2025 | Tysabri, Vumerity |
| Alexion Pharmaceuticals, INC. | $142.76 | 2025 | Ultomiris |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kim Ham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.